SUBSCRIBE
SUBSCRIBE
News   FDA

Ranbaxy Laboratories Launches Herpes Drug in the U.S.

November 30, 2009 | 
1 min read
Bookmark and Share

Reuters -- Ranbaxy Laboratories, India's top drug maker by sales, has launched a generic version of GlaxoSmithKline's Valtrex in the United States with a 180-day marketing exclusivity, a company spokesman said on Friday.
FDA Approvals
GSK
MORE ON THIS TOPIC
Find Business Growth Opportunity, Business Standing Analyzing Arrow Gate
Rare diseases
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
May 27, 2026
 · 
3 min read
 · 
Heather McKenzie
Vaccines
Lilly just bought renowned regulator Peter Marks a pipeline to play with
May 27, 2026
 · 
2 min read
 · 
Annalee Armstrong
Creative pattern made with a syringe on pastel pink background. Vaccine for Coronavirus infection. Pandemic concept.
COVID-19
FDA assembles vaccine experts to update COVID-19 formulation
May 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Breast cancer
AstraZeneca’s breast cancer pill hit with review delay after negative adcomm vote
May 27, 2026
 · 
4 min read
 · 
Tristan Manalac